(Q77467836)

English

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

scientific article published on 01 August 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J M Buesa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A López-Pousa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Martín

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Antón

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J García del Muro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Bellmunt

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Arranz

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

V Valentí

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

P Escudero

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Menéndez

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Casado

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Poveda

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

871-876

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosing and side-effects of ifosfamide plus mesna

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

The enigma of ifosfamide encephalopathy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide by continuous infusion to prevent encephalopathy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008474802882

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77467836&oldid=1566684283"